Pancreatic neuroendocrine tumors

Cancer

Volumn 115, Issue 4, 2009, Pages 741-751

  Hill, Joshua S ^a   McPhee, James T ^a   McDade, Theodore P ^a   Zhou, Zheng ^a   Sullivan, Mary E ^a   Whalen, Giles F ^a   Tseng, Jennifer F ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

End results (seer) database; Epidemiology; Pancreatic neuroendocrine tumors; Pancreatic resection; Surveillance; Survival advantage

Indexed keywords

ADULT; ARTICLE; CANCER LOCALIZATION; CANCER REGISTRY; CANCER SURGERY; CANCER SURVIVAL; DISEASE COURSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; NEUROENDOCRINE TUMOR; PANCREAS TUMOR; PATIENT IDENTIFICATION; PRIMARY TUMOR; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

AGED; FEMALE; HEALTH PLANNING GUIDELINES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEUROENDOCRINE TUMORS; PANCREATIC NEOPLASMS; PROGNOSIS; RISK FACTORS; SEER PROGRAM; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 60849106654     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24065     Document Type: Article

References (33)

1. Grimelius L, Hultquist GT, Stenkvist B. Cytological differentiation of asymptomatic pancreatic islet cell tumours in autopsy material. Virchows Arch A Pathol Anat Histol. 1975; 365:275-288.
2. Weber KJ, Lin J, Prinz RA. Endocrine tumors of the pancreas: clinical picture, diagnosis and therapy. In: Blumgart LH, ed. Surgery of the Liver, Biliary Tract, and Pancreas. Vol 1. Philadelphia: Saunders Elsevier; 2007:904-914.
3. Phan GQ, Yeo CJ, Hruban RH, Lillemoe KD, Pitt HA, Cameron JL. Surgical experience with pancreatic and peri- pancreatic neuroendocrine tumors: review of 125 patients. J Gastrointest Surg. 1998; 2:472-482.
4. Vagefi PA, Razo O, Deshpande V, et al. Evolving patterns in the detection and outcomes of pancreatic neuroendocrine neoplasms: the Massachusetts General Hospital experience from 1977 to 2005. Arch Surg. 2007; 142:347-354.
5. Prinz RA, Dorsch TR, Lawrence AM. Clinical aspects of glucagon-producing islet cell tumors. Am J Gastroenterol. 1981; 76:125-131.
6. Schurr PG, Strate T, Rese K, et al. Aggressive surgery improves long-term survival in neuroendocrine pancreatic tumors: an institutional experience. Ann Surg. 2007; 245: 273-281.
7. Norton JA. Endocrine tumours of the gastrointestinal tract: surgical treatment of neuroendocrine metastases. Baillieres Best Pract Res Clin Gastroenterol. 2005; 19:577-583.
8. ixon E, Pasieka JL. Functioning and nonfunctioning neu- roendocrine tumors of the pancreas. Curr Opin Oncol. 2007; 19:30-35.
9. Fraker DL, Norton JA, Alexander HR, Venzon DJ, Jensen RT. Surgery in Zollinger-Ellison syndrome alters the natural history of gastrinoma. Ann Surg. 1994; 220:320-328.
10. Norton JA, Fraker DL, Alexander HR, et al. Surgery to cure the Zollinger-Ellison syndrome. N Engl J Med. 1999; 341:635.
11. Chamberlain RS, Canes D, Brown KT, et al. Hepatic neu- roendocrine metastases: does intervention alter outcomes? J Am Coll Surg. 2000; 190:432-445.
12. Sarmiento JM, Heywood G, Rubin J, Ilstrup DM, Nagor- ney DM, Que FG. Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival. J Am Coll Surg. 2003; 197:29-37.
13. Sarmiento JM, Que FG. Hepatic surgery for metastases from neuroendocrine tumors. Surg Oncol Clin N Am. 2003; 12:231-242.
14. Solorzano CC, Lee JE, Pisters PW, et al. Nonfunctioning islet cell carcinoma of the pancreas: survival results in a contemporary series of 163 patients. Surgery. 2001; 130: 1078-1085.
15. Nagorney DM, Atwell T D, ue FG. Hepatic metastases from primary neuroendocrine tumors. In: Blumgart LH, ed. Surgery of the Liver, Biliary Tract, and Pancreas. Vol 1. Philadelphia: Saunders Elsevier; 2007:1195-1209.
16. Greene FL, Page DL, Fleming ID, et al., eds. AJCC Cancer Staging Manual. 6th ed. New York: Springer; 2002.
17. Bilimoria KY, Bentrem DJ, Merkow RP, et al. Application of the pancreatic adenocarcinoma staging system to pancreatic neuroendocrine tumors. JAmCollSurg.2007; 205:558-563.
18. Solcia E, Kloppel G, Sobin LH, eds. Histologic Typing of Endocrine Tumors. World Health Organization International Histology Classification of Tumours. 2nd ed. New York: Springer; 2000.
19. Capella C, Heitz PU, Hofler H, Solcia E, Kloppel G. Revised classification of neuroendocrine tumours of the lung, pancreas and gut. Virchows Arch. 1995; 425:547-560.
20. Kloppel G, Perren A, Heitz PU. The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification. Ann N Y Acad Sci. 2004; 1014:13-27.
21. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958; 185:1457-1481.
22. Modlin IM. A 5-decade analysis of 13,715 carcinoid tumors. Cancer. 2003; 97:934.
23. Yao JC. Population-based study of islet cell carcinoma. Ann Surg Oncol. 2007; 14:3492.
24. Bilimoria KY. Clinicopathologic features and treatment trends of pancreatic neuroendocrine tumors: analysis of 9,821 patients. J Gastrointest Surg. 2007; 11:1460.
25. Grazi GL, Cescon M, Pierangeli F, et al. Highly aggressive policy of hepatic resections for neuroendocrine liver metastases. Hepatogastroenterology. 2000; 47:481-486.
26. Norton JA, Kivlen M, Li M, Schneider D, Chuter T, Jensen RT. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors. Arch Surg. 2003; 138:859-866.
27. Norton JA, Warren RS, Kelly MG, Zuraek MB, Jensen RT. Aggressive surgery for metastatic liver neuroendocrine tumors. Surgery. 2003; 134:1057-1063.
28. Que FG, Nagorney DM, Batts KP, Linz LJ, Kvols LK. Hepatic resection for metastatic neuroendocrine carcinomas. Am JSurg. 1995; 169:36-42.
29. Ringe B, Lorf T, Dopkens K, Canelo R. Treatment of hepatic metastases from gastroenteropancreatic neuroendo- crine tumors: role of liver transplantation. World J Surg. 2001; 25:697-699.
30. Touzios JG, Kiely JM, Pitt SC, et al. Neuroendocrine hepatic metastases: does aggressive management improve survival? Ann Surg. 2005; 241:776-783.
31. Kazanjian KK, Reber HA, Hines OJ. Resection of pancreatic neuroendocrine tumors: results of 70 cases. Arch Surg. 2006; 141:765-769.
32. Riall, Nealon TS, Goodwin WH, et al. Pancreatic cancer in the general population: improvements in survival over the last decade. JGastrointest Surg. 2006; 10:1212.
33. Bilimoria KY, Bentrem DJ, Ko CY, Stewart AK, Winchester DP, Talamonti MS. National failure to operate on early stage pancreatic cancer. Ann Surg. 2007; 246:173-180.